Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials
In Japan, the choice of anti-diabetic medication is officially recommended according to the patient ’s glycemic condition and disease phenotype, unlike most other regions where metformin is recommended as the f...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Atsushi Tanaka and Koichi Node Tags: Commentary Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Heart | Japan Health | Metformin